Literature DB >> 7812538

Effect of cooling on oxygen consumption in febrile critically ill patients.

C A Manthous1, J B Hall, D Olson, M Singh, W Chatila, A Pohlman, R Kushner, G A Schmidt, L D Wood.   

Abstract

Hyperthermic critically ill patients are commonly cooled to reduce their oxygen consumption (VO2). However, no previous studies in febrile humans have measured VO2 during cooling. We cooled 12 febrile, critically ill, mechanically ventilated patients while measuring VO2 and CO2 production (VCO2) by analysis of inspired and expired gases. All patients were mechanically ventilated for hypoxemic, hypercapneic, or shock-related respiratory failure and had a mean APACHE II score of 22.4 +/- 7.7. As temperature was reduced from 39.4 +/- 0.8 to 37.0 +/- 0.5 degrees C, VO2 decreased from 359.0 +/- 65.0 to 295.1 +/- 57.3 ml/min (p < 0.01) and VCO2 decreased from 303.6 +/- 43.6 to 243.5 +/- 37.3 ml/min (p < 0.01). The respiratory quotient (RQ) did not change significantly, and calculated energy expenditure decreased from 2,481 +/- 426 to 1,990 +/- 33 kcal/day (p < 0.01). In 7 patients with right heart catheters, cardiac output decreased from 8.4 +/- 3.2 to 6.5 +/- 1.8 L/min (p < 0.01) as the oxygen extraction fraction also tended to decrease from a mean of 28.2 +/- 6.8 to 23.4 +/- 4.7% (p = 0.12) during cooling. Accordingly, cooling the febrile patient unloads the cardiorespiratory system and, in situations of limited oxygen delivery or hypoxemic respiratory failure, may thus facilitate resuscitation and minimize the potential for hypoxic tissue injury.

Entities:  

Mesh:

Year:  1995        PMID: 7812538     DOI: 10.1164/ajrccm.151.1.7812538

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  55 in total

1.  Clinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock.

Authors:  Nicholas M Mohr; Brian M Fuller; Lee P Skrupky; Hawnwan Moy; Robert Alunday; Scott T Micek; Richard E Fagley
Journal:  Ann Pharmacother       Date:  2011-09-20       Impact factor: 3.154

2.  Fever: suppress or let it ride?

Authors:  Juliet J Ray; Carl I Schulman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 3.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

4.  Fever is associated with delayed ventilator liberation in acute lung injury.

Authors:  Giora Netzer; David W Dowdy; Thelma Harrington; Satish Chandolu; Victor D Dinglas; Nirav G Shah; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl Shanholtz; Jeffrey D Hasday; Dale M Needham
Journal:  Ann Am Thorac Soc       Date:  2013-12

5.  What We Do When We Suppress Fever.

Authors:  Philip A Mackowiak
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 6.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

Review 7.  Primary immune surveillance: some like it hot.

Authors:  Joseph J Skitzki; Qing Chen; W C Wang; Sharon S Evans
Journal:  J Mol Med (Berl)       Date:  2007-08-18       Impact factor: 4.599

8.  Counterpoint: Should antipyretic therapy be given routinely to febrile patients in septic shock? No.

Authors:  Anne M Drewry; Richard S Hotchkiss
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

9.  A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.

Authors:  J Steven Hata; Constance R Shelsky; Bradley J Hindman; Thomas C Smith; Jonathan S Simmons; Michael M Todd
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  Acetaminophen has limited antipyretic activity in critically ill patients.

Authors:  Rachel S Greenberg; Hegang Chen; Jeffrey D Hasday
Journal:  J Crit Care       Date:  2009-09-24       Impact factor: 3.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.